John B Porter, Patrick B Walter, Lynne D Neumayr, Patricia Evans, Sukhvinder Bansal, Maciej Garbowski, Marcela G Weyhmiller, Paul R Harmatz, John C Wood, Jeffery L Miller, Colleen Byrnes, Guenter Weiss, Markus Seifert, Regine Grosse, Dagmar Grabowski, Angelica Schmidt, Roland Fischer, Peter Nielsen, Charlotte Niemeyer, Elliott Vichinsky
Journal: British journal of haematology 2015;167(5):692-6
PMID: 25209728
In transfusional iron overload, extra-hepatic iron distribution differs, depending on the underlying condition. Relative mechanisms of plasma non-transferrin bound iron (NTBI) generation may account for these differences. Markers of iron metabolism (plasma NTBI, labile iron, hepcidin, transferrin, monocyte SLC40A1 [ferroportin]), erythropoiesis (growth differentiation factor 15, soluble transferrin receptor) and tissue hypoxia (erythropoietin) were compared in patients with Thalassaemia Major (TM), Sickle Cell Disease and Diamond-Blackfan Anaemia (DBA), with matched transfusion histories. The most striking differences between these conditions were relationships of NTBI to erythropoietic markers, leading us to propose three mechanisms of NTBI generation: iron overload (all), ineffective erythropoiesis (predominantly TM) and low transferrin-iron utilization (DBA).
© 2014 John Wiley & Sons Ltd.
Full Text Sources:
Medical:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.